From there each plan is designed from your data, whether that is cagrilintide alone, cagrilintide combined with a GLP-1 medication, or a broader plan that adds hormone optimization and nutritional support
ApoB is particularly useful in patients with hypertriglyceridemia, diabetes, metabolic syndrome, obesity, very low LDL-C on therapy, suspected discordance, premature ASCVD, or persistent risk despite apparently controlled LDL-C
The readout is expected in the first half of 2026
Using medication past its BUD means you are injecting a product with unknown potency and potentially compromised sterility
What are the functions of peptides
Not in the traditional sense